Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma

This study has been completed.
Information provided by (Responsible Party):
Oslo University Hospital Identifier:
First received: August 9, 2007
Last updated: May 3, 2012
Last verified: May 2008